Neurodiagnostics Market - Consainsights

01

Executive Summary

Global Neurodiagnostics Market Size, 2017-2026 (USD Billion)

The global neurodiagnostics market size is expected to grow from USD 6.20 billion in 2020 to USD 8.91 billion by 2026 at a CAGR of 6.2%.

Demand for neurodiagnostics products is expected to grow mainly due to factors such as increased morbidity and morbidity, technological advances, patient-focused growth in early and early diagnosis, a growing number of diagnostic centers and hospitals, and the use of biomarker printing diagnostics.

The market, by condition, is divided into neurodegenerative diseases, epilepsy, stroke, headache disorders, sleep disorders, and other conditions (includes autism, schizophrenia, Williams syndrome, Landau-Kleffner syndrome, depression, attention-deficit hyperactivity disorder (ADHD), and dyslexia). In 2019, the neurodegenerative diseases segment is expected to account for the largest share in the neurodiagnostics market. The increasing increase in traumatic brain injury, dementia, Parkinson's disease, and Huntington's disease, as well as the growing number of neurological tests for these conditions, are leading to the growth of this market segment.

By end-user, the market is divided into hospitals & surgical centers, diagnostic laboratories & imaging centers, neurology centers, ambulatory care centers (ACCs), and research laboratories & academic institutes. In 2020, hospitals & surgical centers had the largest share in the neurodiagnostics market. A large proportion of this category of end-users may be mainly due to the financial capacity of hospitals to purchase expensive equipment, such as neurodiagnostic devices. Hospitals also have the highest number of trained specialists in performing complex diagnostic procedures using neurodiagnostic tools than any other end users, which is one of the factors contributing to market growth.

North America had the largest market share. North America is a well-established market for medical devices. The availability of a highly developed health care system, the high acceptance of new neurodiagnostic tools among medical professionals, the full availability of high-quality neurodiagnostic tools, and the large number of companies producing low-level neurodiagnostic devices or major US driving capabilities market in North America.

The major players in the neurodiagnostics market are Thermo Fisher Scientific, Inc. (US), GE Healthcare (US), Bio-Rad Laboratories (US), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), Canon, Inc. (Japan), Natus Medical Incorporated (US), Hoffman-La Roche AG (Switzerland), Hitachi, Ltd. (Japan), FUJIFILM Holdings Corporation (Japan), Mitsar Co., Ltd. (Russia), Lifelines Neuro Company, LLC (US), QIAGEN N.V. (Netherlands), Advanced Brain Monitoring (US), and Nihon Kohden Corporation (Japan).

Revenue Share (%), By Product (2019)
Revenue Share (%), By Condition (2019)
Revenue Share (%), By End User (2019)
Revenue Share (%), By Region (2019)

02

Market Overview

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.
The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.
The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.
Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.
Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.
As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.
For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.
For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

03

By Condition

By Condition, The global Neurodiagnostics Market analysis covers Epilepsy, Headache Disorders, Neurodegenerative Diseases, Sleep Disorders, Stroke.

The Epilepsy segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Epilepsy: global Neurodiagnostics Market Revenue Opportunity (Us$ Mn)

The Headache Disorders segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Headache Disorders: global Neurodiagnostics Market Revenue Opportunity (Us$ Mn)

The Neurodegenerative Diseases segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Neurodegenerative Diseases: global Neurodiagnostics Market Revenue Opportunity (Us$ Mn)

The Sleep Disorders segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Sleep Disorders: global Neurodiagnostics Market Revenue Opportunity (Us$ Mn)

The Stroke segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Stroke: global Neurodiagnostics Market Revenue Opportunity (Us$ Mn)

04

By Product

By Product, The global Neurodiagnostics Market analysis covers Clinical Diagnostic Instruments, Diagnostic Imaging Systems, Reagents & Consumables.

The Clinical Diagnostic Instruments segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Clinical Diagnostic Instruments: global Neurodiagnostics Market Revenue Opportunity (Us$ Mn)

The Diagnostic Imaging Systems segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Diagnostic Imaging Systems: global Neurodiagnostics Market Revenue Opportunity (Us$ Mn)

The Reagents & Consumables segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Reagents & Consumables: global Neurodiagnostics Market Revenue Opportunity (Us$ Mn)

05

By Region

By Region, The global Neurodiagnostics Market analysis covers Asia Pacific, Europe, Latin America, Middle East & Africa, North America.

The Asia Pacific segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Asia Pacific: global Neurodiagnostics Market Revenue Opportunity (Us$ Mn)

The Europe segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Europe: global Neurodiagnostics Market Revenue Opportunity (Us$ Mn)

The Latin America segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Latin America: global Neurodiagnostics Market Revenue Opportunity (Us$ Mn)

The Middle East & Africa segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Middle East & Africa: global Neurodiagnostics Market Revenue Opportunity (Us$ Mn)

The North America segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

North America: global Neurodiagnostics Market Revenue Opportunity (Us$ Mn)

06

By End User

By End User, The global Neurodiagnostics Market analysis covers Ambulatory Care Centers, Diagnostic Laboratories & Imaging Centers, Hospitals & Surgical Centers, Neurology Centers, Research Laboratories & Academic Institutes.

The Ambulatory Care Centers segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Ambulatory Care Centers: global Neurodiagnostics Market Revenue Opportunity (Us$ Mn)

The Diagnostic Laboratories & Imaging Centers segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Diagnostic Laboratories & Imaging Centers: global Neurodiagnostics Market Revenue Opportunity (Us$ Mn)

The Hospitals & Surgical Centers segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Hospitals & Surgical Centers: global Neurodiagnostics Market Revenue Opportunity (Us$ Mn)

The Neurology Centers segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Neurology Centers: global Neurodiagnostics Market Revenue Opportunity (Us$ Mn)

The Research Laboratories & Academic Institutes segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Research Laboratories & Academic Institutes: global Neurodiagnostics Market Revenue Opportunity (Us$ Mn)

08

Europe

Based on the Europe, the Neurodiagnostics Market analysis covers Germany, United Kingdom, France, Spain, Russia, Italy, Rest of Europe.

Europe Neurodiagnostics Size, 2019-2027 (Us$ Mn) — Europe Neurodiagnostics Market Size, 2019-2027 (Us$ Mn)

Europe Neurodiagnostics Market - Historical, Forecast Market Sizes (US$ MN), By Condition, 2019-2027

Europe Neurodiagnostics Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027

Europe Neurodiagnostics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027

Germany Neurodiagnostics Market - Historical, Forecast Market Sizes (US$ MN), By Condition, 2019-2027

Germany Neurodiagnostics Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027

Germany Neurodiagnostics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027

United Kingdom Neurodiagnostics Market - Historical, Forecast Market Sizes (US$ MN), By Condition, 2019-2027

United Kingdom Neurodiagnostics Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027

United Kingdom Neurodiagnostics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027

France Neurodiagnostics Market - Historical, Forecast Market Sizes (US$ MN), By Condition, 2019-2027

France Neurodiagnostics Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027

France Neurodiagnostics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027

Spain Neurodiagnostics Market - Historical, Forecast Market Sizes (US$ MN), By Condition, 2019-2027

Spain Neurodiagnostics Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027

Spain Neurodiagnostics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027

Russia Neurodiagnostics Market - Historical, Forecast Market Sizes (US$ MN), By Condition, 2019-2027

Russia Neurodiagnostics Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027

Russia Neurodiagnostics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027

Italy Neurodiagnostics Market - Historical, Forecast Market Sizes (US$ MN), By Condition, 2019-2027

Italy Neurodiagnostics Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027

Italy Neurodiagnostics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027

Rest of Europe Neurodiagnostics Market - Historical, Forecast Market Sizes (US$ MN), By Condition, 2019-2027

Rest of Europe Neurodiagnostics Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027

Rest of Europe Neurodiagnostics Market - Historical, Forecast Market Sizes (US$ MN), By End User, 2019-2027

08

Asia-Pacific

Based on the Asia-Pacific, the Neurodiagnostics Market analysis covers China, Japan, India, Southeast Asia, Australia & New Zealand, Rest of Asia-Pacific.